MedPath

Acute Health Effects of Short-term Use of E-cigarettes on Pulmonary and Cardiovascular System

Not Applicable
Completed
Conditions
E-cigarette
Interventions
Behavioral: E-cigarette use
Behavioral: Simulation of the use of e-cigarette
Behavioral: Cigarette smoking
Registration Number
NCT03742700
Lead Sponsor
Medical University of Silesia
Brief Summary

The goal of our study was to assess acute, short term respiratory (airflow, FeNO, O2 saturation, exhaled air temperature) and cardiovascular (heart rate, blood pressure) responses to smoking an e-cigarette in exclusive e-smokers and dual users and to compare these effects with responses to smoking a tobacco-cigarette in exclusive tobacco smokers.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
120
Inclusion Criteria
  • smoking status (cigarette or e-cigarette smoking)
Exclusion Criteria
  • occurrence of any chronic diseases,
  • history of lung conditions (eg.: asthma or bronchial hyperactivity in childhood),
  • presence of any allergic diseases,
  • medication intake within the last 2 weeks,
  • acute illnesses or infections in the last 2 weeks,
  • influenza vaccination in the last 2 weeks,
  • or current pregnancy or lactation.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SEQUENTIAL
Arm && Interventions
GroupInterventionDescription
T/E-smokersE-cigarette useT/E-smokers (dual users) were instructed to use e-cigarettes (12 mg/ml nicotine) in accordance with everyday habits for 5 minutes.
Control subjectsSimulation of the use of e-cigaretteThe control subjects were asked to simulate the use of e-cigarettes (a device without e-liquid where aerosol was not created or inhaled).
T-smokersCigarette smokingT-smokers were asked to smoke a cigarette of one of the popular brands (0.6mg nicotine per one cigarette) according to their everyday habits.
E-smokersE-cigarette useE-smokers were instructed to use e-cigarettes (12 mg/ml nicotine) in accordance with everyday habits for 5 minutes.
Primary Outcome Measures
NameTimeMethod
temperature of exhaled airpre - post (1 minute after exposure) - post (30 minute after exposure)

The measurement was made using the standard procedure in the sitting position using an X-Halo Breath Thermometer \[20\]. Respondents were instructed to breathe according to the procedure recommended by the device manufacturer. The temperature of exhaled air was expressed in Celsius degrees (°C).

exhaled carbon monoxide (CO)pre - post (1 minute after exposure) - post (30 minute after exposure)

During the measurement, requirements regarding the length and intensity of the exhalation were taken into account. The measurements were made using the PiCo Smokylyzer device. The measured CO levels were expressed in ppm (parts per million).

spirometric testingpre - post (1 minute after exposure) - post (30 minute after exposure)

Airflow and lung volume were measured in the sitting position with a noseclip according to the ATS/ERS guidelines. The measurements were made using the EasyOne 2001 spirometer and included FEV1, FVC, FEV1% FVC, PEF and MEF75,50,25. Expiratory maneuvers were repeated until a minimum of three technically correct, repeatable measurements were obtained.

heart ratepre - post (1 minute after exposure) - post (30 minute after exposure)

Heart rate was measured in the sitting position, the result of measurement was expressed in beats per minute.

Concentration of nitric oxide (FeNO)pre - post (1 minute after exposure) - post (30 minute after exposure)

FeNO measurements were made using the standard procedure in the sitting position with a clip attached to the nose using a NIOX MINO device for measuring fractional exhaled nitric oxide (FeNO). Subjects were instructed to breathe as deeply as possible through the mouthpiece to achieve maximum lung filling and then to exhale 50ml/sec for 10s. The measured FeNO values were expressed in ppb (parts per billion).

O2 saturationpre - post (1 minute after exposure) - post (30 minute after exposure)

The O2 measurement was made in the sitting position using the PULSOX 2 electronic pulse meter. The result was recorded 15 seconds after the start of the measurement.

blood pressurepre - post (1 minute after exposure) - post (30 minute after exposure)

Blood pressure was measured in the sitting position, the result of measurement was expressed in mmHg.

Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath